BioSpace News Archive

A new research paper, funded by the Reboot Foundation, outlines effective strategies for combating misinformation campaigns, particularly around the COVID-19 pandemic.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the European Medicines Agency (EMA) has granted its request for accelerated assessment of valoctocogene roxaparvovec, for adults with severe hemophilia A.

Dyadic International, Inc. a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, announced that the Company will participate in the following upcoming events

AcuityMD , a platform for commercializing and improving medical devices with data, announced today the close of a $7 million financing round led by Benchmark with participation from Ajax Health. Eric Vishria, General Partner at Benchmark will also join AcuityMD’s board of directors.

Appointment is Effective May 24, 2021 Mr. Velis will continue his role on Noveome’s Board of Directors William J. Golden steps down as CEO, remains as Founder and Chairman of the Board of Directors

Aspekt Solutions , a leading provider of radiation oncology and radiology solutions, is pleased to announce the acquisition of Nordic Medical Physics. This strategic acquisition increases the consulting capabilities and expands the geographic footprint of Aspekt Solutions.

Machine vision innovator SiLC Technologies, Inc. today announced a $17 million Series A funding round led by Alter Venture Partners and Dell Technologies Capital with additional participation from Fluxunit

Ainos, Inc., f/k/a Amarillo Biosciences, Inc. (OTC PINK:AIMD), is pleased to announce that the Financial Industry Regulatory Authority, Inc. approved the Companys name change to Ainos, Inc. and AIMD as its new ticker symbol. Effective today, the Companys common stock will trade under the symboll AIMD

electroCore’s nVNS device transformed the field of headache therapy and seeks to revolutionize other treatment areas like COVID-19 associated migraine, post-traumatic headache, stroke, Parkinson’s disease and other neurological, and inflammatory conditions

Bioclinica, an ERT company, today announced receiving 2021 CRO Leadership Awards for four consecutive years in multiple performance categories.